--- title: HR 1532. National Ovarian Cancer Awareness Month; September 2026; support designation collection: bills id: 2025-2026/hr1532 cite_as: HR 1532, 2025-2026 Regular Session (Ga.) canonical_url: https://georgiacommons.org/bills/2025-2026/hr1532 md_url: https://georgiacommons.org/bills/2025-2026/hr1532.md text_url: https://georgiacommons.org/bills/2025-2026/hr1532/text source_url: https://www.legis.ga.gov/legislation/73801 date: 2026-03-06 status: introduced corpus_version: bills-2026-09-13 license: Public record of the Georgia General Assembly, via LegiScan; see about.md publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice. up: https://georgiacommons.org/bills/2025-2026.md previous: https://georgiacommons.org/bills/2025-2026/hr1531.md next: https://georgiacommons.org/bills/2025-2026/hr1533.md index: https://georgiacommons.org/bills/index.md omitted: votes and history omitted_chars: 132 omitted_url: https://georgiacommons.org/bills/2025-2026/hr1532.md?full=1 bill_number: HR 1532 session: 2025-2026 Regular Session session_slug: 2025-2026 chamber: House bill_type: resolution status_date: 2026-03-03 last_action: House Second Readers sponsors: - Lisa Campbell - Shea Roberts - Mekyah McQueen - Kimberly Alexander - Darlene Taylor - Sheila Jones text_version: Introduced has_text: true legiscan_url: https://legiscan.com/GA/bill/HR1532/2025 upstream_id: 2128598 summaries_model: claude-sonnet-5 topic_tags: - ovarian cancer - women's health - cancer awareness - health disparities --- # HR 1532. National Ovarian Cancer Awareness Month; September 2026; support designation ## Text House Resolution 1532 By: Representatives Campbell of the 35th, Roberts of the 52nd, McQueen of the 61st, Alexander of the 66th, Taylor of the 173rd, and others A RESOLUTION Supporting the designation of September 2026 as National Ovarian Cancer Awareness Month; and for other purposes. WHEREAS, ovarian cancer is the fifth-leading cause of cancer deaths of women in the United States and causes more deaths than any other gynecologic cancer; and WHEREAS, in the United States, a woman's lifetime risk of being diagnosed with ovarian cancer is about one in 91; and WHEREAS, the American Cancer Society estimates 20,890 cases of ovarian cancer will be newly diagnosed in 2026, and 12,730 individuals will die from the disease nationwide; and WHEREAS, the five-year survival rate for ovarian cancer is 51.6 percent, and survival rates vary greatly depending on the stage of diagnosis; and WHEREAS, the five-year survival rate for ovarian cancer is over 90 percent for individuals diagnosed in early stages; and WHEREAS, while the mammogram can detect breast cancer and the pap smear can detect cervical cancer, there is no reliable early detection test for ovarian cancer; and WHEREAS, in June 2007, the first national consensus statement on ovarian cancer symptoms was developed to provide consistency in describing symptoms to make it easier for women to learn and remember those symptoms; and WHEREAS, Black women with ovarian cancer are more likely to have late-stage diagnoses, receive lower quality clinical services, and have lower five-year survival rates than non-Black women; and WHEREAS, Black women have a five-year ovarian cancer mortality rate of 62 percent, while the five-year ovarian cancer mortality rate is 54 percent for White women; and WHEREAS, women of color, low-income women, and women living in rural areas have more barriers to accessing a standard quality of care and are more likely to receive care at a facility that has poorer adherence to National Comprehensive Cancer Network treatment guidelines; and WHEREAS, the proportion of ovarian cancer cases in women serving on active duty who are less than 45 years of age is substantially greater than in the general population; and WHEREAS, too many people remain unaware that the symptoms of ovarian cancer often include bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, urinary symptoms, and several other vague symptoms that are often easily confused with other diseases; and WHEREAS, improved awareness of the symptoms of ovarian cancer by the public and health care providers can lead to quicker diagnoses and more treatment opportunities; and WHEREAS, the lack of an early detection test for ovarian cancer combined with its vague symptoms mean that approximately 80 percent of cases of ovarian cancer are detected at an advanced stage; and WHEREAS, issues collecting and reporting data on treatment and outcomes related to ovarian cancer risk, especially for underserved communities and marginalized populations, can impede the development of effective policy; and WHEREAS, all women are at risk for ovarian cancer, but approximately 20 percent of women who are diagnosed with ovarian cancer have a hereditary predisposition to ovarian cancer, which places them at even higher risk; and WHEREAS, scientists and physicians have uncovered changes in the BRCA genes that some women inherit from their parents, which may make those women 30 times more likely to develop ovarian cancer; and WHEREAS, the family history of a woman has been found to play an important role in accurately assessing her risk of developing ovarian cancer, and medical experts believe that family history should be taken into consideration during the annual well-woman visit of any woman; and WHEREAS, those women who have a family history of ovarian or breast cancer should consider genetic testing and counseling to determine whether their risk of developing a heritable cancer is elevated; and WHEREAS, women who know that they are at high risk of ovarian cancer may undertake prophylactic measures like an opportunistic salpingectomy to help reduce the risk of developing this disease; and WHEREAS, guidelines issued by the National Comprehensive Cancer Network and the Society of Gynecologic Oncology recommend that all individuals diagnosed with ovarian cancer receive genetic counseling and genetic testing regardless of their family history; and WHEREAS, studies consistently show that compliance with these guidelines is alarmingly low, with recently published National Cancer Institute-funded research finding that in 2013 and 2014, only one-third of ovarian cancer survivors have undergone such testing; and WHEREAS, according to a 2016 consensus report by the National Academy of Medicine, "there remain surprising gaps in the fundamental knowledge about and understanding of ovarian cancer" across all aspects of the disease; and WHEREAS, ovarian cancer research remains underfunded relative to its mortality rate, making increased Federal investment critical to progress; and WHEREAS, ongoing investments in ovarian cancer research and education and awareness efforts are critical to closing these gaps and improving survivorship for women with ovarian cancer; and WHEREAS, each year during the month of September, the Ovarian Cancer Research Alliance and community partner organizations hold a number of events to increase public awareness of ovarian cancer and its symptoms; and WHEREAS, to increase public awareness of ovarian cancer, September 2026 should be designated as National Ovarian Cancer Awareness Month. NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES that the members of this body support the goals and ideals of the designation of September 2026 as National Ovarian Cancer Awareness Month. BE IT FURTHER RESOLVED that the Clerk of the House of Representatives is authorized and directed to make appropriate copies of this resolution available for distribution to the public and the press. ## Summaries written by Georgia Commons The following was written by claude-sonnet-5 from the text above and is not part of the resolution. Quote the text, not the summary. A Georgia House resolution would express support for designating September 2026 as National Ovarian Cancer Awareness Month, citing statistics on ovarian cancer's death toll and detection challenges. ### Plain-language summary This is a resolution, not a law, so it does not change any Georgia statute or create new requirements. It lays out a long list of findings about ovarian cancer, including its death rate, survival statistics, the lack of an early detection test, disparities affecting Black women and other underserved groups, and the role of genetic testing and family history in assessing risk. Based on those findings, the House resolves that its members support the goals of designating September 2026 as National Ovarian Cancer Awareness Month. It also directs the Clerk of the House of Representatives to make copies of the resolution available to the public and the press. The resolution does not fund any program, create any office, or amend any Georgia code section. ### What it does - States the Georgia House's support for the national designation of September 2026 as National Ovarian Cancer Awareness Month. - Recites statistics on ovarian cancer death rates, survival rates, and diagnosis stages without creating any binding legal requirement. - Directs the Clerk of the House of Representatives to distribute copies of the resolution to the public and the press. - Does not appropriate funding, create a program, or amend any existing Georgia law. ### Who it affects The resolution mainly affects public awareness efforts around ovarian cancer. It references women in general, Black women and other women of color, low-income and rural women, and women serving on active duty in the military, as groups facing higher risk or worse outcomes from the disease. ### Why it matters Because this is a symbolic resolution rather than a law, it does not change medical care, funding, or screening requirements in Georgia. Its practical effect is limited to expressing legislative support and directing distribution of the resolution's text to the public and press. ### Key provisions - The whereas clauses recite statistics on ovarian cancer, including a 51.6 percent five-year survival rate and roughly 80 percent of cases detected at an advanced stage. - The resolving clause states that House members support the goals and ideals of designating September 2026 as National Ovarian Cancer Awareness Month. - A further resolving clause directs the Clerk of the House of Representatives to make copies available for distribution to the public and the press. ## Status - Status: Introduced (2026-03-03) - Last action: House Second Readers (2026-03-06) - Sponsors: Lisa Campbell, Shea Roberts, Mekyah McQueen, Kimberly Alexander, Darlene Taylor, Sheila Jones - Official page: https://www.legis.ga.gov/legislation/73801 > The history, votes, and amendments (132 characters) are at https://georgiacommons.org/bills/2025-2026/hr1532.md?full=1